成人急性髓系白血病中NUP98重排的临床意义及新融合伙伴鉴定
该研究通过靶向捕获测序在1569例成人AML中检出41例NUP98重排,占4753例髓系肿瘤中44例NUP98重排的大多数。研究鉴定出15种融合伙伴,包括NUP98::MEOX2和NUP98::HOXA6两种新融合,并揭示NUP98重排AML复发率更高、无事件生存更短,异基因造血干细胞移植与更好生存相关。
要点
- NUP98重排在成人AML中占一定比例,NUP98::NSD1和NUP98::HOXA9最常见。
- NUP98重排AML复发率更高、无事件生存更短,NUP98::NSD1诱导缓解差。
- 异基因造血干细胞移植与NUP98重排AML更好生存相关。
核心结论
- NUP98重排成人AML具有遗传和临床异质性,支持将其归类为独立疾病实体。
- 不同融合伙伴需采取特异性的治疗策略。
研究设计与样本
- 使用靶向捕获测序,在1569例AML中鉴定出41例NUP98重排。
- 在4753例髓系肿瘤中检出44例NUP98重排,本研究41例占大多数。
主要发现
- 检测到15种不同融合伙伴,NUP98::NSD1和NUP98::HOXA9最常见。
- 发现两种新融合:NUP98::MEOX2和NUP98::HOXA6。
- FLT3-ITD和WT1突变最常见,NPM1突变仅见于特定病例。
- FLT3-ITD在NUP98::NSD1病例中显著富集,TET2突变在NUP98::HOXA9病例中更常见。
- NUP98重排AML复发率更高、无事件生存更短;NUP98::NSD1诱导缓解差,NUP98::HOXA9及其他伙伴融合缓解率高但复发频繁。
关键数值与推荐
- NUP98重排AML复发率更高且无事件生存更短。
- NUP98::NSD1与诱导缓解差相关。
- NUP98::HOXA9及其他伙伴融合缓解率更高但复发频繁。
- 异基因造血干细胞移植与更好生存相关。
临床怎么用
- 对成人AML进行NUP98重排检测有助于风险分层。
- 识别融合伙伴可指导制定特异性治疗策略。
- 异基因造血干细胞移植应考虑用于NUP98重排AML患者。
局限性
- NUP98重排在成人AML中患病率、遗传特征和临床意义仍需进一步表征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
NUP98 rearrangements represent a distinct, high-risk subtype of acute myeloid leukemia (AML), particularly in pediatric patients. However, their prevalence, genetic features, and clinical implications in adult AML remain poorly characterized. Using targeted-capture sequencing, we identified 41 cases with NUP98 rearrangements among 1569 AML cases, representing the majority of 44 NUP98-rearranged cases detected across 4753 myeloid neoplasms. Fifteen distinct fusion partners were detected, with NUP98::NSD1 and NUP98::HOXA9 being the most frequent. Notably, two novel fusions-NUP98::MEOX2 and NUP98::HOXA6-were identified. Co-mutations were relatively infrequent; FLT3-ITD and WT1 mutations were the most common, while NPM1 mutations were exclusive. FLT3-ITD was significantly enriched in NUP98::NSD1 cases, whereas TET2 mutations were more frequent in NUP98::HOXA9 cases. Clonal hierarchy analysis suggested that NUP98 rearrangements occur early in leukemogenesis. NUP98-rearranged AML exhibited higher relapse rates and shorter event-free survival. Specifically, NUP98::NSD1 was associated with a poor induction response, whereas NUP98::HOXA9 and NUP98 fusions with other partners showed higher remission rates but frequent relapse. Allogeneic hematopoietic stem cell transplantation was associated with better survival, underscoring its significance. These findings reveal the genetic and clinical heterogeneity of NUP98-rearranged AML in adults and support its classification as a distinct entity, highlighting the need for fusion partner-specific therapeutic strategies.
引用
- Chonabayashi K, Iwasaki M, Kanda J, et al. NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners. Leukemia. 2026. PMID: 41501506. doi:10.1038/s41375-025-02848-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。